Skip to main content
Premium Trial:

Request an Annual Quote

French Agency Awards Transgene $33M for Pharmacogenomics Program

NEW YORK (GenomeWeb News) - Transgene said today that the French Agency for Industrial Innovation has awarded it €25 million ($32.7 million) to participate in a pharmacogenomics project called ADNA (Advanced Diagnostics and New therapeutic Approaches).
ADNA includes four partners -- Transgene, bioMerieux, Genethon, and GenoSafe -- and aims to improve personalized medicine in the fields of cancer, infectious diseases, and rare genetic diseases.
According to a statement from Transgene, the “core” of the program will be the development and validation of biomarkers to help guide the prescription of new treatments to those patients most likely to benefit from them.
The funding is subject to European Commission approval, which is expected in the second quarter of 2007, Transgene said.
The funding includes grants of €17.8 million and loans of €7.2 million refundable only in the case of success.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.